NexImmune, Inc. Common Stock
NEXI
NEXI was delisted on the 11th of July, 2024.
42 hedge funds and large institutions have $119M invested in NexImmune, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 14 increasing their positions, 14 reducing their positions, and 6 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 14
1.98% less ownership
Funds ownership: 44.98% → 42.99% (-2%)
9% less funds holding
Funds holding: 46 → 42 (-4)
36% less capital invested
Capital invested by funds: $185M → $119M (-$65.9M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.77M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.86M |
| 3 |
JP Morgan Chase
New York
|
+$2.06M |
| 4 |
State Street
Boston,
Massachusetts
|
+$871K |
| 5 |
BlackRock
New York
|
+$387K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
-$3.93M |
| 2 |
Millennium Management
New York
|
-$1.62M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.17M |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$822K |
| 5 |
HI
HBK Investments
Dallas,
Texas
|
-$572K |
NEXI Hedge Fund Activity: Q2 2021 in Review
42 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in NexImmune, Inc. Common Stock (NEXI) for Q2 2021, worth a combined $119M — down 36% from $185M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NEXI and 2 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 14 added.
The largest buyer was Adage Capital Partners, adding an estimated $3.77M. The largest seller was Suvretta Capital Management, cutting an estimated $3.93M.
- 42 institutional investors held NexImmune, Inc. Common Stock (NEXI) as of Q2 2021, down from 46 in Q1 2021.
- Funds reported $119M of NexImmune, Inc. Common Stock stock for Q2 2021, down 36% quarter-over-quarter.
- 2 funds opened new NexImmune, Inc. Common Stock positions in Q2 2021 and 6 closed out, a net change of -4 holders.
- The largest NexImmune, Inc. Common Stock buyer in Q2 2021 was Adage Capital Partners, an estimated $3.77M added.
- The largest NexImmune, Inc. Common Stock seller in Q2 2021 was Suvretta Capital Management, an estimated $3.93M sold.
Based on aggregated 13F filings for Q2 2021.